News from gbi research A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 31, 2016, 10:00 ET US Opioid Market to Surpass $17 Billion by 2021 Despite Substance Abuse Concerns, Says GBI Research

A new report from business intelligence provider GBI Research - Opioids Overview to 2021: An Assessment of Pain Management and Dependence - states...


Mar 29, 2016, 11:00 ET Substance Abuse Treatment Pipeline Dominated by Nicotine and Alcohol Addiction Treatments, Says GBI Research

A new report from business intelligence provider GBI Research - Substance Abuse Deterrents and Treatments: An Assessment of the Technological,...


Mar 22, 2016, 09:00 ET Asia-Pacific Alzheimer's Disease Market to Hit $5.1 Billion by 2021, says GBI Research

A new report from business intelligence provider GBI Research - Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - states that the...


Mar 17, 2016, 08:00 ET Monoclonal Antibodies Headline Innovation in Gastric Cancer Treatment Pipeline, says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Gastric Cancer -states that while 99% of currently marketed gastric...


Mar 08, 2016, 10:00 ET Asia-Pacific Asthma Market Hit $3.5 Billion in 2014 and Will Reach $5.6 Billion by 2021, Says GBI Research

A new report from business intelligence provider GBI Research - Asthma Therapeutics in Asia-Pacific Markets to 2021 - states that the asthma...


Mar 03, 2016, 09:00 ET Government Healthcare Budgets Could Benefit Hugely from Global Telehealth Market, Says GBI Research Government Healthcare Budgets Could Benefit Hugely from Global Telehealth Market, Says GBI Research

A new report from business intelligence provider GBI Research - Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies -...


Mar 01, 2016, 08:00 ET Breast Cancer is Most Productive Pipeline with 1,050 Drugs in Development, says GBI Research

A new report from business intelligence provider GBI Research - Frontier Pharma: Breast Cancer - states that the breast cancer treatment pipeline's...


Feb 25, 2016, 10:00 ET Parkinson's Disease Market Will Exceed $3 Billion by 2021 Despite Little Advance Towards a Cure, Says GBI Research

A new report from business intelligence provider GBI Research - Parkinson's Disease Therapeutics in Major Developed Markets to 2021 - states that the ...


Feb 11, 2016, 11:00 ET Breast Cancer Market in APAC Region Hit $1.9 Billion in 2014 and Will Reach $3.4 Billion by 2021, says GBI Research

A new report from business intelligence provider GBI Research - Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - states that the...


Feb 10, 2016, 11:00 ET Alzheimer's Disease Market Will Surpass $10 Billion by 2021, Says GBI Research

A new report from business intelligence provider GBI Research - Alzheimer's Disease Therapeutics Market to 2021 - states that the Alzheimer's disease ...


Feb 04, 2016, 10:00 ET Health Economics and Outcome Research is Crucial to Pharmaceutical Market Access Strategies, Says GBI Research

A new report from business intelligence provider GBI Research - Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major...


Jan 28, 2016, 08:00 ET Global Immunology Market Will Hit $74.2 Billion by 2022, says GBI Research

A new report from business intelligence provider GBI Research - Global Immunology Market to 2022 - states that the global immunology treatment market ...


Jan 26, 2016, 10:00 ET APAC Type 2 Diabetes Market Hit $6.1 Billion in 2014 and Will Pass $10 Billion by 2021, says GBI Research

A new report from business intelligence provider GBI Research - Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - states that...


Jan 21, 2016, 07:00 ET Despite Mixed Attitudes Towards Biobanking, Demand Will Continue to Grow, Says GBI Research

Demand for biobanks will continue to increase in North America and Europe despite various ethical and financial concerns, says GBI Research. A report ...


Jan 19, 2016, 08:00 ET Treatment Pipeline for COPD Fails to Address Many Unmet Needs, Says GBI Research

The Chronic Obstructive Pulmonary Disease (COPD) treatment pipeline lacks innovation despite an influx of new therapies, says GBI Research. Analysis...


Jan 14, 2016, 09:00 ET Six New Drugs Will Drive Pancreatic Cancer Treatment Market to $2.9 Billion by 2021, says GBI Research

Pancreatic cancer treatment market will grow from its current level of $1.9 billion, with increased disease prevalence also a factor, says GBI...


Jan 12, 2016, 07:00 ET Parkinson's Disease Treatment Pipeline is Likely to Meet Many Unmet Needs, says GBI Research

The treatment pipeline for Parkinson's disease offers a markedly more promising landscape from the current market, says GBI Research. Analysis from...


Jan 07, 2016, 07:00 ET Higher Breast Cancer Rates Will Push Treatment Market Beyond $17 Billion by 2021, says GBI Research

The global breast cancer therapeutics market will increase in value from $10.4 billion in 2014 to $17.2 billion by 2021, says GBI Research. Analysis...


Jan 06, 2016, 08:00 ET Future Over-the-counter Drugs Market Will Include More Complex Diseases, Says GBI Research

Demand for Over-the-Counter (OTC) drugs is rising as patients are taking a more proactive approach to treating ailments, says GBI Research. Analysis...


Dec 23, 2015, 07:00 ET APAC Anti-hypertensive Therapy Market Hit $15.7 Billion in 2014 and Will Reach $19.9 Billion by 2021, says GBI Research

Modest market growth will be primarily due to the lack of hypertension awareness, which leads to low diagnosis and treatment rates, says GBI Research....


Dec 22, 2015, 07:00 ET APAC Multiple Myeloma Therapy Market Hit $1.7 Billion in 2014 and Will Add $1.1 Billion by 2021, says GBI Research

Emergence of novel therapeutics and minimal generic competition in China, Japan and Australia will drive APAC multiple myeloma market growth to 2021, ...


Dec 16, 2015, 08:00 ET Future Obesity Drugs Must Provide Improved Efficacy and Safety, says GBI Research

A highly innovative and diverse pipeline of 248 products in active development is set to tackle the ever-encroaching obesity crisis, says GBI...


Dec 14, 2015, 07:00 ET Liver Cancer Treatment Pipeline Aiming to Address Major Unmet Needs, says GBI Research

Diverse pipeline of 218 products could help to transform the liver cancer treatment space over next 10 years, says GBI Research. Analysis from...


Dec 09, 2015, 09:00 ET Gene Therapy Pipeline Has More Than 900 Products in Active Development, Says GBI Research

Early-stage gene therapy pipeline particularly strong, with 76% of products at either the Discovery or Preclinical stage, says GBI Research Analysis...


Dec 08, 2015, 11:00 ET Over 50% of Ovarian Cancer Treatment Pipeline Products Are First-in-Class, Says GBI Research

Ovarian cancer treatment has a strong pipeline of 462 diverse and innovative products in active development, says GBI Research. Analysis from...